PharmaCyte forced to think outside the box as CEO departs amid ongoing clinical hold

PharmaCyte forced to think outside the box as CEO departs amid ongoing clinical hold

Submitted by admin on October 9, 2022 - 5:54pm
Source: 
Fierce Biotech
News Tags: 
PharmaCyte
Pharma CEOs
cell-in-a-box
Headline: 
PharmaCyte forced to think outside the box as CEO departs amid ongoing clinical hold
snippet: 

Long-time PharmaCyte CEO Kenneth Waggoner has departed the biotech, leaving amid a cost freeze on all programs and an ongoing clinical hold on its “Cell-in-a-Box” technology.

Do Not Allow Advertisers to Use My Personal information